#8 How do we change behaviour around antimicrobial resistance?
Listen now
Description
Uppsala Health Summit participants Otto Cars, Eldar Shafir and Vanessa Carter provide their perspective on managing antimicrobial resistance through behaviour change.
More Episodes
Published 02/29/24
Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the...
Published 02/29/24
The liver is the primary site for drug metabolism in the body, but it can be severely damaged by medicines or their toxic compounds. Rita Baião from the North Lisbon University Hospital Center reviews what pharmacovigilance professionals should know about drug-induced liver injury (DILI). Tune...
Published 02/01/24